Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript February 15, 2024
Pacific Biosciences of California, Inc. reports earnings inline with expectations. Reported EPS is $-0.31 EPS, expectations were $-0.31. Pacific Biosciences of California, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Hello and welcome to the PacBio Fourth Quarter 2023 Earnings Conference Call. All...
